|
WO2009111892A1
|
|
Microrna mediated oncolytic targeting
|
|
WO2009067808A1
|
|
Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors
|
|
WO2009015473A1
|
|
Hydraulic articulating joint
|
|
US2009275504A1
|
|
PCSK9 polypeptide fragment
|
|
CA2630510A1
|
|
Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
|
|
CA2625811A1
|
|
Microrna mediated oncolytic targeting
|
|
WO2008037090A1
|
|
Apparatus and method for separate optical measurements of specularly and diffusely reflected light
|
|
EP2083687A1
|
|
Correlation technique for analysis of clinical condition
|
|
CA2658584A1
|
|
Staged immune-response modulation in oncolytic therapy
|
|
US2010086522A1
|
|
Disparate suicide carrier cells for tumor targeting of promiscuous oncolytic viruses
|
|
US2009081195A1
|
|
Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility
|
|
CN101305052A
|
|
Interpenetrating networks, and related methods and compositions
|
|
CA2548881A1
|
|
Neoglycopolymer-cross-linked biopolymer matrix
|
|
US2006206043A1
|
|
Articulating joint
|
|
CA2524619A1
|
|
Novel stem cells, nucleotide sequences and proteins therefrom
|
|
CA2576308A1
|
|
Ophthalmic devices and related methods and compositions
|
|
WO2005066345A1
|
|
Diabetogenic epitopes
|
|
EP1639097A2
|
|
Methods and compositions for modulating stem cell growth and differentiation
|
|
CA2570464A1
|
|
Use of cardiotrophin to modulate stem cell proliferation
|
|
US7384784B2
|
|
Pax-encoding vector and use thereof
|
